-
Sector Analysis
United Kingdom (UK) Statutory and Private Employee Benefits, 2023 Update
United Kingdom (UK) Statutory and Private Employee Benefits Overview The UK has one of the most comprehensive and well-established welfare systems in the world. It is predominantly controlled by the social security system. Welfare benefits in the country are disbursed under various schemes, such as cash benefits, healthcare, education, childcare housing, and personal social services. Cash benefits are classified into three subgroups: national insurance; means-tested; and non-contributory benefits. The United Kingdom employee benefits report provides in-depth industry analysis, information, and...
-
Track & Monitor
Innovation in Automotive: Accelerator threshold-based speed control
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Accelerator threshold-based speed control segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Analyst Opinions
Wealth Management Competitive Dynamics – Review of Wealth Managers by AUM, Financial Performance and Competitive Trends
Wealth Management Competitive Dynamics Report Overview After 2021 saw double-digit growth in client assets and record profits, the private wealth management industry looks set for its toughest year since the global financial crisis. A combination of expansionary monetary policy and pandemic support created fertile market conditions for private wealth managers in 2021, but 2022 is set to be the polar opposite – saddling competitors with significant challenges and headwinds. The wealth management competitive dynamics research report benchmarks the AUM and...
-
Product Insights
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Meningitis Pipeline Drugs Market Report Overview Meningitis is the inflammation caused by viruses and bacteria on the protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening. Viral meningitis is not life-threatening and the people affected with this can be cured and recover quickly, but bacterial meningitis...
-
Thematic Analysis
Robotics in Retail and Apparel – Thematic Intelligence
Robotics in Retail and Apparel Thematic Report Overview Robotics is gaining prominence across multiple industries. High-growth industry leaders have streamlined their logistics and supply chain networks by incorporating robotics into their processes. While requiring upfront investment, robotics in warehouses significantly reduces operating expenses, driving efficiency and accuracy. The robotics in retail and apparel thematic intelligence report assesses how robotics, combined with other emerging technologies, can be used across the retail and apparel value chain. It provides an overview of the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ebselen
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ebselen Drug Details SPI-1005 (ebselen) is under development for the treatment of bipolar disorder,...
-
Product Insights
Anaphylaxis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anaphylaxis Pipeline Drugs Market Overview Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma and family history. Treatment includes beta-agonist, antihistamines and cortisone. The Anaphylaxis pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target,...
-
Product Insights
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a hospital or long-term care facility. Symptoms include cough, fever, shaking chills, confusion, headache and loss of appetite. Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis and diabetes mellitus. Treatment includes antibiotics and healthy lifestyle. The Community-acquired Pneumonia Drugs in Development market research report provides an in-depth analysis of the Community-acquired Pneumonia pipeline landscape. The report provides comprehensive information on the therapeutics under...
-
Sector Analysis
Australia – Healthcare, Regulatory and Reimbursement Landscape
GlobalData, the industry analysis specialist, has released its latest report: “Australia - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses...
-
Analyst Opinions
Towards Next Generation Asset Class – Can NFTs Outlive Hype as New Gold of Crypto Economy?
The NFT market grew by more than 2,000% to surpass $2 billion in Q1 2021 sales. It sprung to $2.5 billion by the first half of 2021. NFTs maintained more than 1% of the Ethereum and 0.17% of the Bitcoin market capitalization in 2020. NFTs unfold a new frontier in the use case of blockchain technology to monetize digital creative content. Slowly but surely, they are proving to be bigger than an art fad by finding real-time use cases in...